本页面由Tiger Trade Technology Pte. Ltd.提供服务

West Pharmaceutical Services Inc

250.64
+5.502.24%
盘后250.640.00000.00%19:54 EDT
成交量:79.78万
成交额:2.00亿
市值:180.32亿
市盈率:36.91
高:252.27
开:248.31
低:245.92
收:245.14
52周最高:322.34
52周最低:187.43
股本:7,194.34万
流通股本:7,141.24万
量比:0.90
换手率:1.12%
股息:0.85
股息率:0.34%
每股收益(TTM):6.79
每股收益(LYR):6.79
净资产收益率:16.85%
总资产收益率:10.09%
市净率:5.68
市盈率(LYR):36.91

数据加载中...

2024/12/11

重要事件披露

Form 8-K - Current report
2024/10/24

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/24

重要事件披露

Form 8-K - Current report
2024/10/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/23

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/08

重要事件披露

Form 8-K - Current report
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

重要事件披露

Form 8-K - Current report
2024/07/08

重要事件披露

Form 8-K - Current report
2024/06/26

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/26

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

重要事件披露

Form 8-K - Current report
2024/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report